Dexbrompheniramine and phenylephrine and Siltuximab Intravenous
Determining the interaction of Dexbrompheniramine and phenylephrine and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexbrompheniramine and phenylephrine-Silvadene
- Dexbrompheniramine and phenylephrine-Silvadene Topical
- Dexbrompheniramine and phenylephrine-SilvaSorb
- Dexbrompheniramine and phenylephrine-Silver
- Dexbrompheniramine and phenylephrine-Silver Nitrate
- Dexbrompheniramine and phenylephrine-Silver Nitrate Applicators
- Siltuximab Intravenous-Dexbrompheniramine and Phenylephrine Syrup
- Siltuximab Intravenous-Dexbrompheniramine and Phenylephrine Tablets
- Siltuximab Intravenous-Dexbrompheniramine and pseudoephedrine
- Siltuximab Intravenous-Dexbrompheniramine and Pseudoephedrine Solution
- Siltuximab Intravenous-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Siltuximab Intravenous-Dexbrompheniramine and Pseudoephedrine Tablets